Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed
- 1 January 2003
- journal article
- Published by Elsevier in Cytotherapy
- Vol. 5 (1) , 40-45
- https://doi.org/10.1080/14653240310000065
Abstract
The aim of this study was to determine the influence and significance of different aspiration sites and the number of mononuclear cells (MNC) analyzed on the frequency of isolated tumor cell (ITC) detection by immunocytochemistry (ICC) in BM aspirates from breastcancer patients. BM aspirates were collected from the two anterior and two posterior crests just prior to primary surgery. The BM was processed separately from the anterior and the posterior crests, and cytospins (2 × 106 MNC) were prepared for ICC examination. The remaining cells were pooled, followed by cytospin preparation and ICC analysis (2 × 106 MNC/ test). In addition, a fraction of the pooled cells were further processed by negative immunomagnetic selection, for enrichment of ITC. Out of 100 patients selected, 97 were further analyzed. The ICC examination from the separate crests revealed 37 positive BMs from the anterior iliac crest and 30 positive from the posterior crest. Twenty-one of the samples were positive at both sides. Five patients had 10 or more ITCs detected. In these, an unequal distribution of ITCs between the sides was observed, but in fovor of neither. ICC analysis of 2, 4 and 6 × 106 MNC revealed respectively 22, 46 and 52 positive BMs out of the 97 analyzed. These results were correlated to the clinical outcome after a median 43 months follow-up. Thirteen of the patients underwent systemic relapse. Analyzing 2 × 106 rf MNC by ICC, 27.3% of the BM+ patients developed systemic disease, compared with 9.3% of the BM÷ patients (P = 0.0056, log rank test). Analyzing 2 × 106 MNC reduced the correlation between ITC in BM and clinical outcome. No significant difference in the detection rate of ITCs from the anterior and the posten’or iliac crests was found, although the distribution of ITCs did show a great van·ability. Analyzing a higher number of BM cells increased the number of positive BM specimens detected. However, this increased detection rate reduces the prediction by ICC of early systemic relapse.Keywords
This publication has 13 references indexed in Scilit:
- Use of automated microscopy for the detection of disseminated tumor cells in bone marrow samplesCytometry, 2001
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cellsCytotherapy, 1999
- Clinical Relevance of Detection of Tumor Cells in the Bone Marrow of Primary Breast Cancer Patients: A ReviewOncology Research and Treatment, 1997
- Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal StatusJNCI Journal of the National Cancer Institute, 1996
- Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-upBritish Journal of Cancer, 1994
- Methodological Analysis of Immunocytochemical Screening for Disseminated Epithelial Tumor Cells in Bone MarrowJournal of Hematotherapy, 1994
- Detection and Characterization of Residual Disease in Breast CancerJournal of Hematotherapy, 1994
- Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-upEuropean Journal of Cancer and Clinical Oncology, 1991
- Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimens of breast cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1990